Works matching IS 15257304 AND DT 2021 AND VI 22 AND IP 5
Results: 42
Table of Contents.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. A2, doi. 10.1016/S1525-7304(21)00202-3
- Publication type:
- Article
Editorial Board.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. A1, doi. 10.1016/S1525-7304(21)00201-1
- Publication type:
- Article
Prognostic Value of Computed Tomography and/or 18F-Fluorodeoxyglucose Positron Emission Tomography Radiomics Features in Locally Advanced Non-small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 461, doi. 10.1016/j.cllc.2021.03.015
- By:
- Publication type:
- Article
Three Decades of Malignant Pleural Mesothelioma: An Academic Center Experience.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 441, doi. 10.1016/j.cllc.2021.03.011
- By:
- Publication type:
- Article
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 449, doi. 10.1016/j.cllc.2021.03.010
- By:
- Publication type:
- Article
Biomarkers of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer: Beyond PD-L1.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 381, doi. 10.1016/j.cllc.2021.03.006
- By:
- Publication type:
- Article
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 423, doi. 10.1016/j.cllc.2021.03.005
- By:
- Publication type:
- Article
Management of Oligometastasis and Oligoprogression in Patients with Epidermal Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e786, doi. 10.1016/j.cllc.2021.03.004
- By:
- Publication type:
- Article
Osimertinib-induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e784, doi. 10.1016/j.cllc.2021.03.003
- By:
- Publication type:
- Article
NF1-Mutant Cancer and Immune Checkpoint Inhibitors: A Large Database Analysis.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 480, doi. 10.1016/j.cllc.2021.03.002
- By:
- Publication type:
- Article
The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 432, doi. 10.1016/j.cllc.2021.03.001
- By:
- Publication type:
- Article
Management of Cutaneous Immunotherapy Toxicities.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e783, doi. 10.1016/j.cllc.2021.02.017
- By:
- Publication type:
- Article
Letter to the Editor Regarding "Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy".
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e782, doi. 10.1016/j.cllc.2021.02.016
- By:
- Publication type:
- Article
Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 473, doi. 10.1016/j.cllc.2021.02.014
- By:
- Publication type:
- Article
Extra-axial Chordoma Masquerading as Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e658, doi. 10.1016/j.cllc.2021.02.013
- By:
- Publication type:
- Article
Where Is the Primary Site of the Extra-Axial Chordoma Masquerading As Lung Cancer?
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e655, doi. 10.1016/j.cllc.2021.02.012
- By:
- Publication type:
- Article
Lung Resection Without Tissue Diagnosis: A Pragmatic Perspective on the Indeterminate Pulmonary Nodule.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e774, doi. 10.1016/j.cllc.2021.02.011
- By:
- Publication type:
- Article
Lobe-specific Lymph Node Dissection for Clinical Stage IA Non–small-cell Lung Cancer: What do we know?
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 478, doi. 10.1016/j.cllc.2021.02.007
- By:
- Publication type:
- Article
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e767, doi. 10.1016/j.cllc.2021.02.005
- By:
- Publication type:
- Article
Lung Cancer and Granuloma Identification Using a Deep Learning Model to Extract 3-Dimensional Radiomics Features in CT Imaging.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e756, doi. 10.1016/j.cllc.2021.02.004
- By:
- Publication type:
- Article
Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non–small-cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e745, doi. 10.1016/j.cllc.2021.02.002
- By:
- Publication type:
- Article
Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 411, doi. 10.1016/j.cllc.2021.02.001
- By:
- Publication type:
- Article
RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 469, doi. 10.1016/j.cllc.2021.01.020
- By:
- Publication type:
- Article
Access to Tyrosine Kinase Inhibitors and Survival in Patients with Advanced EGFR+ and ALK+ Positive Non–small-cell Lung Cancer Treated in the Real-World.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e723, doi. 10.1016/j.cllc.2021.01.019
- By:
- Publication type:
- Article
Immunotherapy and Stereotactic Ablative Radiotherapy for Lung Cancer with Co-existing Interstitial Lung Disease: A Case Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e734, doi. 10.1016/j.cllc.2021.01.018
- By:
- Publication type:
- Article
Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 401, doi. 10.1016/j.cllc.2021.01.017
- By:
- Publication type:
- Article
Predictors of In-Hospital Death in Patients with Lung Cancer Admitted for Acute Radiation Pneumonitis: A Healthcare Cost and Utilization Project (HCUP) Analysis.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e716, doi. 10.1016/j.cllc.2021.01.016
- By:
- Publication type:
- Article
Emergence of NOTCH2-NTRK1 After Osimertinib in a Patient With Lung Adenocarcinoma With Neuroendocrine Differentiation.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e712, doi. 10.1016/j.cllc.2021.01.015
- By:
- Publication type:
- Article
Outcomes of Patients With Interstitial Lung Disease Receiving Programmed Cell Death 1 Inhibitors: A Retrospective Case Series.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e738, doi. 10.1016/j.cllc.2021.01.014
- By:
- Publication type:
- Article
Dramatic Response to Pembrolizumab Monotherapy in a Patient With ARID1A-Mutant Lung Adenocarcinoma: Case Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e708, doi. 10.1016/j.cllc.2021.01.011
- By:
- Publication type:
- Article
Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e703, doi. 10.1016/j.cllc.2021.01.009
- By:
- Publication type:
- Article
Precision Treatment of Advanced Lung Adenocarcinoma With Coexisting EGFR, ALK, and ROS1 Mutations: A Case Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e699, doi. 10.1016/j.cllc.2021.01.008
- By:
- Publication type:
- Article
Racial Disparities in Overall Survival and Surgical Treatment for Early Stage Lung Cancer by Facility Type.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e691, doi. 10.1016/j.cllc.2021.01.007
- By:
- Publication type:
- Article
The Role of Stereotactic Body Radiation Therapy for Pulmonary Carcinosarcoma.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e684, doi. 10.1016/j.cllc.2021.01.005
- By:
- Publication type:
- Article
ALK Rearrangement in Lung Neuroendocrine Neoplasms: Case Series of Non-Asian Patients With Response to ALK Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e686, doi. 10.1016/j.cllc.2021.01.004
- By:
- Publication type:
- Article
Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non–Small-Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e678, doi. 10.1016/j.cllc.2021.01.003
- By:
- Publication type:
- Article
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor–Mutated Non–Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 390, doi. 10.1016/j.cllc.2021.01.002
- By:
- Publication type:
- Article
Targeted Treatment of Multiple Primary Lung Cancers Harboring Distinct EGFR or RET Alterations: A Case Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e673, doi. 10.1016/j.cllc.2020.12.005
- By:
- Publication type:
- Article
Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e668, doi. 10.1016/j.cllc.2020.11.008
- By:
- Publication type:
- Article
Prolonged Disease Control on Nivolumab for Primary Pulmonary NUT Carcinoma.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e665, doi. 10.1016/j.cllc.2020.10.016
- By:
- Publication type:
- Article
STK11/LKB1 Mutation-positive Primary Thymic Mucinous Adenocarcinoma Accompanied by Cerebellar Metastasis: A Case Report and Literature Review.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e659, doi. 10.1016/j.cllc.2020.10.010
- By:
- Publication type:
- Article
Corrigendum to 'Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities': [Clinical Lung Cancer 21(2020) e164-e168].
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e793, doi. 10.1016/j.cllc.2020.07.005
- By:
- Publication type:
- Article